PUBLISHER: Orion Market Research | PRODUCT CODE: 1159172
PUBLISHER: Orion Market Research | PRODUCT CODE: 1159172
Global 3 Phosphoinositide Dependent Protein Kinase 1 Market Size, Share, and Trends Analysis Report by Drug Type (HCI-1708, AR-12, PHT-427, SNS 229, and Others), and by Application (Hospitals, Clinics, and Others) Forecast Period (2022-2028)
The global 3 phosphoinositide dependent protein kinase 1 market is anticipated to grow at a significant CAGR during the forecast period. 3 phosphoinositide dependent kinase 1, also known as PDK1, is a member of the AGC protein kinase family that is involved in a range of cellular processes, including the activation of the PI3K signaling pathway, which has been linked to the start and progression of various human malignancies. The rising prevalence of breast cancer throughout the world is a primary reason driving the market's expansion. According to the World Health Organization (WHO), 2.3 million women were diagnosed with breast cancer in 2020, with 685 000 deaths globally. Breast cancer has been diagnosed in 7.8 million women in the previous five years as of the end of 2020, making it the most common disease in the world.
The global 3 phosphoinositide dependent protein kinase 1 market is segmented based on drug type and application. Based on the drug type, the market is sub-segmented into HCI-1708, AR-12, PHT-427, SNS 229, and others. Based on the application, the market is sub-segment into hospitals, clinics, and others.
The global 3 phosphoinositide dependent protein kinase 1 market is further segmented based on geography including North America, Europe, Asia-Pacific, and the Rest of the World. Among these regions, the Asia-Pacific region is expected to grow at a significant CAGR over the forecast period. Breast cancer is much more common in countries in sub-Saharan Africa and Southeast Asia than in the US. In many of these countries including India, Australia, and others, it is the most common type of cancer among the population. According to the Cancer Council of Australia, in 2020, around 150,000 new cases of cancer and 50,000 deaths were reported due to cancer across the country.
The major companies serving the global 3 phosphoinositide dependent protein kinase 1 market include Boehringer Ingelheim GmbH, AstraZeneca PLC, Arno Therapeutics Inc., Sanofi SA, Novartis International AG, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in November 2020, Merck & Co. Inc. and VelosBio Inc. entered into a definitive agreement. As per the agreement, the Merck acquired all the outstanding shares of VelosBio for $2.75 billion in cash. VelosBio is a privately held clinical-stage biopharmaceutical company committed to developing first-in-class cancer therapies targeting receptor tyrosine kinase-like orphan receptor 1 (ROR1).
Research Methodology
The market study of the global 3 phosphoinositide dependent protein kinase 1 market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, derive total market size, market forecast, and growth rate. We have worked on different approaches to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives as possible, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include:
The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
The Report Covers: